Aggie Spirit fights ALS with festival, massive Ice Bucket Challenge
Former Texas A&M University football player Chris Larkin is returning to the university’s campus in College Station, widely known as…
Articles by Michela Luciano, PhD
Trial testing cannabis-based medicine enrolls first participant
The first participant has been enrolled in a large Italian clinical trial that’s testing Avextra’s cannabis-based medicine for managing…
Scientists ID array of biomarkers that could track ALS progression
Researchers in the U.S. and Europe have identified a number of novel blood and spinal fluid biomarkers that could help…
T-cell therapy CK0803 earns FDA orphan drug designation for ALS
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to CK0803, a regulatory T-cell therapy being developed…
5 students from ALS families in Canada win scholarships
Five students from across Canada whose lives have been directly affected by amyotrophic lateral sclerosis (ALS) received scholarships to…
Weak electrical signals may offer an early ALS diagnosis
Far-field potentials (FFPs), weak electrical signals triggered by nerve stimulation that can be recorded noninvasively on the skin, may serve…
Patient randomization nearly complete in MN-166 trial for ALS
Full randomization is nearly complete in the Phase 2/3 COMBAT-ALS trial testing MN-166 (ibudilast) for the treatment of…
Noninvasive spinal stimulation shown to extend survival in mice
A new treatment approach that noninvasively delivers gentle electrical stimulation to the spinal cord and peripheral nerves — the nerves…
Klotho advances ALS gene therapy KLTO‑202 to manufacturing phase
Klotho Neurosciences is advancing KLTO‑202, its gene therapy candidate for amyotrophic lateral sclerosis (ALS), to the manufacturing and…
Clinicians cite palliative care benefits, barriers to integration
Clinicians view early access to palliative care as beneficial for people with amyotrophic lateral sclerosis (ALS), yet its integration…